Fox Christine Ann has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 315750 shares of Mereo BioPharma Group plc ($MREO) on February 01, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | A | Share Options (Right to buy) | 315750 | $0.00 | 315,750.0000 | 799,947,013 | 9999.99% | 0.04% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | A | Share Options (Right to buy) | 280000 | $0.00 | 280,000.0000 | 799,947,013 | 9999.99% | 0.04% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | A | Share Options (Right to buy) | 105250 | $0.00 | 105,250.0000 | 799,947,013 | 9999.99% | 0.01% |
| Jan. 25, 2025 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | A | Share Options (Right to buy) | 262000 | $0.00 | 262,000.0000 | 739,624,264 | 9999.99% | 0.04% |
| Sept. 13, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | S | American Depositary Shares representing Ordinary Shares | 19158 | $4.22 | 89,285.0000 | 770,146,589 | 17.67% | 0.00% |
| Sept. 12, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | S | American Depositary Shares representing Ordinary Shares | 9128 | $4.47 | 108,443.0000 | 770,146,589 | 7.76% | 0.00% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | M | Performance Based Restricted Stock Unit | 60000 | $0.00 | 0.0000 | 770,146,589 | 100.00% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | M | American Depositary Shares representing Ordinary Shares | 60000 | $0.00 | 117,571.0000 | 770,146,589 | 104.22% | 0.01% |
| June 25, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | S | American Depositary Shares representing Ordinary Shares | 12990 | $3.69 | 87,010.0000 | 659,453,921 | 12.99% | 0.00% |
| June 26, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | S | American Depositary Shares representing Ordinary Shares | 29439 | $3.39 | 57,571.0000 | 659,453,921 | 33.83% | 0.00% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | M | Performance Based Restricted Stock Unit | 90000 | $0.00 | 60,000.0000 | 659,453,921 | 0.00% | 0.01% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | M | American Depositary Shares representing Ordinary Shares | 90000 | $0.00 | 100,000.0000 | 659,453,921 | 900.00% | 0.01% |
| Jan. 25, 2024 | Mereo BioPharma Group plc | $MREO | Fox Christine Ann | Chief Financial Officer | A | Share Options (Right to buy) | 245000 | $0.00 | 245,000.0000 | 659,453,921 | 9999.99% | 0.04% |